Actively Recruiting

Phase Not Applicable
Age: 30Years +
FEMALE
NCT07194551

Assessing Uterine Cancer Risk in Lynch Syndrome Carriers Using Vaginal Self-sampling and a Health Questionnaire

Led by University of British Columbia · Updated on 2025-09-26

30

Participants Needed

1

Research Sites

82 weeks

Total Duration

On this page

Sponsors

U

University of British Columbia

Lead Sponsor

V

Vancouver Coastal Health Research Institute

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal of this study is to find out if self-collected vaginal swabs can be used to detect early signs of uterine cancer or related conditions in people with Lynch syndrome (LS) who still have their uterus. The study also tests if people with LS are willing and able to collect these samples themselves and whether they find the process acceptable. The main questions this study asks are: * Will people with LS take part in self-collection of vaginal samples, and do they find it acceptable? * Can vaginal DNA mutations predict cancer risk or match results from other genetic or biopsy testing? * Can a cancer risk model used in the general population also help identify risk in people with LS? Participants will: * Answer a health questionnaire about lifestyle and symptoms * Collect their own vaginal swabs and measure their vaginal pH at home using a self-collection kit * Complete short surveys around the time of self-collection and at the end of the study

CONDITIONS

Official Title

Assessing Uterine Cancer Risk in Lynch Syndrome Carriers Using Vaginal Self-sampling and a Health Questionnaire

Who Can Participate

Age: 30Years +
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosed with Lynch syndrome confirmed by genetic testing
  • Have an intact uterus
  • Age 30 years or older
Not Eligible

You will not qualify if you...

  • History of endometrial cancer or endometrial hyperplasia
  • History of pelvic radiation or endometrial ablation
  • Pregnant at the time of study enrolment or during the study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

VGH Research Pavilion

Vancouver, British Columbia, Canada, V5Z 1M9

Actively Recruiting

Loading map...

Research Team

A

Aline Talhouk, PhD

CONTACT

R

Research Assistant

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

SCREENING

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Assessing Uterine Cancer Risk in Lynch Syndrome Carriers Using Vaginal Self-sampling and a Health Questionnaire | DecenTrialz